United States

CEBIS Clinical Research Operations

in the United States

CEBIS USA supports clinical research programs through U.S.-based leadership, clinical operations and research-site relationships, coordinated with the organization’s wider international delivery network.

LOCATIONS

U.S. Locations,

One Point of Contact

Houston is the U.S. headquarters and the primary contact point for sponsors with multiple locations across U.S. supporting clinical operations and study logistics.

● Houston, TX
● Boothwyn, PA
●
Houston, TX - Headquarters
●
Berwyn, IL - Operations
●
Dartmouth, MA - Operations
●
Boothwyn, PA - Logistics
HEADQUARTERS

Houston, Texas

CEBIS-USA Inc.
7080 Southwest Fwy, Houston, TX 77074

OPERATIONS

Berwyn, Illinois

6917 West Cermak Road, Berwyn, IL 60402

OPERATIONS

Dartmouth, Massachusetts

237 State Road, Dartmouth, MA 02748

LOGISTICS

Boothwyn, Pennsylvania

7 Chelsea Parkway, Unit 707, Boothwyn, PA 19061

Clinical delivery

Clinical Development

Support for U.S. Programs

U.S. study activity draws on the same integrated functions CEBIS applies across its programs.

Clinical Trial & Project Management
Study planning, milestones and cross-functional coordination.
Site Management & Monitoring
Site identification, start-up, monitoring and closeout support.
Patient Recruitment & Retention
Recruitment and engagement planning based on the protocol and participating sites.
Data Management & Biostatistics
Study data collection, review, analysis and reporting support.
Regulatory Affairs
Regulatory and ethics-related activities aligned with the U.S. study.
Safety & Medical Oversight
Pharmacovigilance and appropriate medical-monitoring support.
Supply & logistics

Clinical Study Logistics Supporting U.S. Sites

Where applicable to the study, CEBIS coordinates clinical supply planning, site distribution, consumable resupply, shipment tracking and temperature-controlled requirements from its Boothwyn, Pennsylvania location.

Global capabilities

U.S. Leadership Connected to International Study Teams

For multinational programs, U.S. study activity stays aligned with clinical operations in Canada, Europe, India and other study-specific markets under one coordinated program.